Clinical and laboratory data of patients with AS treated with infliximab
| Patients (n) | 35 |
| Male/female | 34/1 |
| Age (years), mean (SD) | 42.5 (12.6) |
| Disease duration (years), mean (SD) | 14.5 (8.0) |
| Peripheral arthritis, No (%) | 2 (6) |
| History of uveitis, No (%) | 11 (31) |
| Methotrexate intake, No (%) | 3 (9) |
| Sulfasalazine intake, No (%) | 3 (9) |
| Prednisone intake (5 mg/day), No (%) | 4 (11) |
| NSAIDs, No (%) | 35 (100) |
| HLA-B27, No (%) | 31 (89) |
| BASDAI, mean (SD) | 57.2 (18.5) |
| CRP (mg/l), mean (SD) | 25.6 (17.0) |